Pages that link to "Q34467344"
Jump to navigation
Jump to search
The following pages link to Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia. (Q34467344):
Displaying 50 items.
- Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality (Q26859793) (← links)
- Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 Mice. (Q27319831) (← links)
- Structural Basis for Ligand Recognition and Activation of RAGE (Q27665039) (← links)
- Mouse models to study the effect of cardiovascular risk factors on brain structure and cognition (Q30427103) (← links)
- Immunohistochemical study of N-epsilon-carboxymethyl lysine (CML) in human brain: relation to vascular dementia (Q33302856) (← links)
- Plasma levels of the pro-inflammatory protein S100A12 (EN-RAGE) are associated with muscle and fat mass in hemodialysis patients: a cross-sectional study (Q33723012) (← links)
- Receptor for advanced glycation end products is upregulated in optic neuropathy of Alzheimer's disease (Q33841564) (← links)
- Association of the RAGE G82S polymorphism with Alzheimer's disease (Q33956505) (← links)
- Food intake and blood cholesterol levels of community-based adults with mood disorders (Q34158786) (← links)
- Plasma levels of sRAGE, loss of aeration and weaning failure in ICU patients: a prospective observational multicenter study (Q34749439) (← links)
- Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS) (Q34949171) (← links)
- Plasma levels of soluble receptor for advanced glycation end products in patients with acute respiratory distress syndrome (Q35017280) (← links)
- Serum level of endogenous secretory receptor for advanced glycation end products and other factors in type 2 diabetic patients with mild cognitive impairment (Q35563671) (← links)
- The association of diabetes and dementia and possible implications for nondiabetic populations (Q35619553) (← links)
- Cilostazol attenuates the severity of peripheral arterial occlusive disease in patients with type 2 diabetes: the role of plasma soluble receptor for advanced glycation end-products (Q35882416) (← links)
- Soluble RAGEs - Prospects for treating & tracking metabolic and inflammatory disease (Q35991574) (← links)
- Emerging Targets for Therapeutic Development in Diabetes and Its Complications: The RAGE Signaling Pathway. (Q36207823) (← links)
- Effects of Fructus mume Extract on MAPK and NF-κB Signaling and the Resultant Improvement in the Cognitive Deficits Induced by Chronic Cerebral Hypoperfusion (Q36537983) (← links)
- RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease (Q36942363) (← links)
- RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases (Q36969021) (← links)
- Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease (Q37068847) (← links)
- Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent? (Q37072018) (← links)
- Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene (Q37233185) (← links)
- Receptor for advanced glycation end products: its role in Alzheimer's disease and other neurological diseases (Q37259863) (← links)
- Nodes and biological processes identified on the basis of network analysis in the brain of the senescence accelerated mice as an Alzheimer's disease animal model. (Q37261529) (← links)
- Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests. (Q37270464) (← links)
- Levels of Soluble Receptor for Advanced Glycation End Products in Acute Ischemic Stroke without a Source of Cardioembolism (Q37384595) (← links)
- Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury (Q37393702) (← links)
- Complex tissue-specific patterns and distribution of multiple RAGE splice variants in different mammals (Q37430071) (← links)
- Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer's disease (Q37578319) (← links)
- Soluble forms of RAGE in internal medicine. (Q37591246) (← links)
- Crosstalk between calcium, amyloid beta and the receptor for advanced glycation endproducts in Alzheimer's disease (Q37602130) (← links)
- Possible implications of insulin resistance and glucose metabolism in Alzheimer's disease pathogenesis (Q37857377) (← links)
- What is the role of the receptor for advanced glycation end products-ligand axis in liver injury? (Q37857797) (← links)
- Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain (Q37977251) (← links)
- Reasons to Investigate the Soluble Receptor for Advanced Glycation End-Product (sRAGE) Pathway in Aortic Disease (Q38370045) (← links)
- Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective. (Q38686477) (← links)
- Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda (Q38851823) (← links)
- RAGE-TLR Crosstalk Sustains Chronic Inflammation in Neurodegeneration (Q39123617) (← links)
- AGEs/sRAGE, a novel risk factor in the pathogenesis of end-stage renal disease (Q39313922) (← links)
- Receptor for Advanced Glycation End Products and its Inflammatory Ligands are Upregulated in Amyotrophic Lateral Sclerosis. (Q41871282) (← links)
- The S100B/RAGE Axis in Alzheimer's Disease (Q42151789) (← links)
- Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases. (Q42176457) (← links)
- Elevated Plasma Level of Soluble Form of RAGE in Ischemic Stroke Patients with Dementia. (Q46316960) (← links)
- Advanced glycation end products (AGEs) and its receptors in the pathogenesis of hyperthyroidism (Q46593328) (← links)
- sRAGE alleviates neutrophilic asthma by blocking HMGB1/RAGE signalling in airway dendritic cells (Q47133236) (← links)
- Synthetic Fragment of Receptor for Advanced Glycation End Products Prevents Memory Loss and Protects Brain Neurons in Olfactory Bulbectomized Mice. (Q47865490) (← links)
- Correlation among soluble markers and severity of disease in non-diabetic subjects with pre-mature coronary artery disease. (Q47890970) (← links)
- Neurodegenerative Markers are Increased in Postmortem BA21 Tissue from African Americans with Alzheimer's Disease (Q50958699) (← links)
- Association between intraoperative ventilator settings and plasma levels of soluble receptor for advanced glycation end-products in patients without pre-existing lung injury (Q50959034) (← links)